- call +1-201-465-4211
- email sales@mrinsights.biz
Description
Scope of the Report:
The global NGS-based RNA-sequencing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of NGS-based RNA-sequencing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the NGS-based RNA-sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the NGS-based RNA-sequencing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Illumina
Eurofins Scientific
Agilent Technologies
Thermo Fischer Scientific
QIAGEN
Oxford Nanopore
Takara Bio
PerkinElmer
BGI
Roche
Tecan Genomics
GENEWIZ
Zymo Research
Hamilton
Macrogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Market Segment by Applications, can be divided into
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 NGS-based RNA-sequencing Market Overview
1.1 Product Overview and Scope of NGS-based RNA-sequencing
1.2 Classification of NGS-based RNA-sequencing by Types
1.2.1 Global NGS-based RNA-sequencing Revenue Comparison by Types (2019-2024)
1.2.2 Global NGS-based RNA-sequencing Revenue Market Share by Types in 2018
1.2.3 Sequencing by Synthesis
1.2.4 Ion Semiconductor Sequencing
1.2.5 Single-molecule Real-time Sequencing
1.2.6 Nanopore Sequencing
1.3 Global NGS-based RNA-sequencing Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global NGS-based RNA-sequencing Market by Regions
1.4.1 Global NGS-based RNA-sequencing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) NGS-based RNA-sequencing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) NGS-based RNA-sequencing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS-based RNA-sequencing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) NGS-based RNA-sequencing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS-based RNA-sequencing Status and Prospect (2014-2024)
1.5 Global Market Size of NGS-based RNA-sequencing (2014-2024)
2 Company Profiles
2.1 Illumina
2.1.1 Business Overview
2.1.2 NGS-based RNA-sequencing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Illumina NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eurofins Scientific
2.2.1 Business Overview
2.2.2 NGS-based RNA-sequencing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eurofins Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 NGS-based RNA-sequencing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Thermo Fischer Scientific
2.4.1 Business Overview
2.4.2 NGS-based RNA-sequencing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.5 QIAGEN
2.5.1 Business Overview
2.5.2 NGS-based RNA-sequencing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 QIAGEN NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.6 Oxford Nanopore
2.6.1 Business Overview
2.6.2 NGS-based RNA-sequencing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Oxford Nanopore NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Takara Bio
2.7.1 Business Overview
2.7.2 NGS-based RNA-sequencing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Takara Bio NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.8 PerkinElmer
2.8.1 Business Overview
2.8.2 NGS-based RNA-sequencing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PerkinElmer NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.9 BGI
2.9.1 Business Overview
2.9.2 NGS-based RNA-sequencing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BGI NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Roche
2.10.1 Business Overview
2.10.2 NGS-based RNA-sequencing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.11 Tecan Genomics
2.11.1 Business Overview
2.11.2 NGS-based RNA-sequencing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Tecan Genomics NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.12 GENEWIZ
2.12.1 Business Overview
2.12.2 NGS-based RNA-sequencing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 GENEWIZ NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.13 Zymo Research
2.13.1 Business Overview
2.13.2 NGS-based RNA-sequencing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Zymo Research NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.14 Hamilton
2.14.1 Business Overview
2.14.2 NGS-based RNA-sequencing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Hamilton NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
2.15 Macrogen
2.15.1 Business Overview
2.15.2 NGS-based RNA-sequencing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Macrogen NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2017-2018)
3 Global NGS-based RNA-sequencing Market Competition, by Players
3.1 Global NGS-based RNA-sequencing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS-based RNA-sequencing Players Market Share
3.2.2 Top 10 NGS-based RNA-sequencing Players Market Share
3.3 Market Competition Trend
4 Global NGS-based RNA-sequencing Market Size by Regions
4.1 Global NGS-based RNA-sequencing Revenue and Market Share by Regions
4.2 North America NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
4.3 Europe NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
4.5 South America NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
5 North America NGS-based RNA-sequencing Revenue by Countries
5.1 North America NGS-based RNA-sequencing Revenue by Countries (2014-2019)
5.2 USA NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
5.3 Canada NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
5.4 Mexico NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
6 Europe NGS-based RNA-sequencing Revenue by Countries
6.1 Europe NGS-based RNA-sequencing Revenue by Countries (2014-2019)
6.2 Germany NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
6.3 UK NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
6.4 France NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
6.5 Russia NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
6.6 Italy NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific NGS-based RNA-sequencing Revenue by Countries
7.1 Asia-Pacific NGS-based RNA-sequencing Revenue by Countries (2014-2019)
7.2 China NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
7.3 Japan NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
7.4 Korea NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
7.5 India NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
8 South America NGS-based RNA-sequencing Revenue by Countries
8.1 South America NGS-based RNA-sequencing Revenue by Countries (2014-2019)
8.2 Brazil NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
8.3 Argentina NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
8.4 Colombia NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue NGS-based RNA-sequencing by Countries
9.1 Middle East and Africa NGS-based RNA-sequencing Revenue by Countries (2014-2019)
9.2 Saudi Arabia NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
9.3 UAE NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
9.4 Egypt NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
9.5 Nigeria NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
9.6 South Africa NGS-based RNA-sequencing Revenue and Growth Rate (2014-2019)
10 Global NGS-based RNA-sequencing Market Segment by Type
10.1 Global NGS-based RNA-sequencing Revenue and Market Share by Type (2014-2019)
10.2 Global NGS-based RNA-sequencing Market Forecast by Type (2019-2024)
10.3 Sequencing by Synthesis Revenue Growth Rate (2014-2024)
10.4 Ion Semiconductor Sequencing Revenue Growth Rate (2014-2024)
10.5 Single-molecule Real-time Sequencing Revenue Growth Rate (2014-2024)
10.6 Nanopore Sequencing Revenue Growth Rate (2014-2024)
11 Global NGS-based RNA-sequencing Market Segment by Application
11.1 Global NGS-based RNA-sequencing Revenue Market Share by Application (2014-2019)
11.2 NGS-based RNA-sequencing Market Forecast by Application (2019-2024)
11.3 Research & Academia Revenue Growth (2014-2019)
11.4 Hospitals & Clinics Revenue Growth (2014-2019)
11.5 Pharmaceutical & Biotechnology Companies Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global NGS-based RNA-sequencing Market Size Forecast (2019-2024)
12.1 Global NGS-based RNA-sequencing Market Size Forecast (2019-2024)
12.2 Global NGS-based RNA-sequencing Market Forecast by Regions (2019-2024)
12.3 North America NGS-based RNA-sequencing Revenue Market Forecast (2019-2024)
12.4 Europe NGS-based RNA-sequencing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific NGS-based RNA-sequencing Revenue Market Forecast (2019-2024)
12.6 South America NGS-based RNA-sequencing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa NGS-based RNA-sequencing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure NGS-based RNA-sequencing Picture
Table Product Specifications of NGS-based RNA-sequencing
Table Global NGS-based RNA-sequencing and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
